本文へ移動
cccskills
無料GitHub で公開

es-cushing-surgical-resection-bilateral-adrenal-disorders

This skill recommends bilateral adrenalectomy for patients with Cushing's syndrome when bilateral adrenal pathology is confirmed as the source of hypercortisolism. Clinical triggers include bilateral macronodular adrenal hyperplasia (BMAH), bilateral adrenal adenomas, or bilateral adrenal carcinoma identified by imaging.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.8 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Surgical Resection of Bilateral Adrenal Disorders for Cushing's Syndrome

STEP 1 — Gather Information

Confirm overt Cushing's syndrome with elevated 24‑h urinary free cortisol or late‑night salivary cortisol; measure plasma ACTH to distinguish ACTH‑independent (<5 pg/mL) from ACTH‑dependent sources; obtain adrenal protocol CT or MRI to assess size, number, and characteristics of adrenal lesions; consider adrenal venous sampling if lateralization is uncertain.

STEP 2 — Rule In / Rule Out

If plasma ACTH is suppressed (<5 pg/mL) indicating an ACTH‑independent (adrenal) source, proceed to evaluate bilateral disease; if ACTH is not suppressed, rule out a primary adrenal etiology and pursue pituitary or ectopic sources instead.

STEP 3 — Classify or Stratify

Classify bilateral adrenal pathology: bilateral macronodular adrenal hyperplasia (multiple nodules >1 cm on both sides), bilateral adenomas (distinct nodules), or bilateral carcinoma (irregular, invasive lesions); unilateral dominant lesion redirects to unilateral adrenalectomy.

STEP 4 — Decide

Recommend bilateral laparoscopic adrenalectomy as definitive treatment; for patients with prohibitive surgical risk or who decline surgery, consider medical therapy to block aberrant hormone receptors (e.g., mifepristone, ketoconazole) as a bridge or palliative option.

Clinical Guardrails / Mimics / Pitfalls

Do not perform unilateral adrenalectomy when bilateral disease is confirmed; avoid relying solely on medical therapy for bilateral adrenal carcinoma; ensure lifelong glucocorticoid and mineralocorticoid replacement postoperatively; monitor for Nelson syndrome if the patient has a history of Cushing’s disease; do not delay surgery in patients with life‑threatening hypercortisolism (e.g., severe infection, thrombosis, psychosis).

Concrete Clinical Example

A 48‑year‑old woman presents with weight gain, hypertension, and undetectable ACTH; CT shows 3.5 cm nodules in both adrenal glands; biochemical testing confirms ACTH‑independent Cushing’s syndrome; she undergoes bilateral laparoscopic adrenalectomy, postoperative cortisol is undetectable, and she is started on hydrocortisone 20 mg/day and fludrocortisone 0.1 mg/day.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., Endocrine Society, 2015, DOI:10.1210/jc.2015-1818

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する